Bioceres Crop Solutions Corp. $BIOX Stock Position Cut by Allianz Asset Management GmbH

Allianz Asset Management GmbH lessened its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 9.8% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 213,488 shares of the company’s stock after selling 23,229 shares during the period. Allianz Asset Management GmbH owned 0.34% of Bioceres Crop Solutions worth $954,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of BIOX. Bank of America Corp DE grew its position in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Ping Capital Management Inc. raised its stake in shares of Bioceres Crop Solutions by 29.5% in the 1st quarter. Ping Capital Management Inc. now owns 57,000 shares of the company’s stock worth $260,000 after buying an additional 13,000 shares in the last quarter. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 25.1% in the 1st quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company’s stock worth $21,125,000 after buying an additional 928,708 shares in the last quarter. Maven Securities LTD raised its stake in shares of Bioceres Crop Solutions by 242.7% in the 1st quarter. Maven Securities LTD now owns 85,673 shares of the company’s stock worth $391,000 after buying an additional 60,673 shares in the last quarter. Finally, Walleye Capital LLC bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter worth $199,000. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

Shares of BIOX opened at $1.84 on Monday. Bioceres Crop Solutions Corp. has a one year low of $1.20 and a one year high of $7.44. The company has a 50-day moving average of $2.05 and a two-hundred day moving average of $3.49. The stock has a market cap of $115.39 million, a price-to-earnings ratio of -2.27 and a beta of 0.33. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Lake Street Capital dropped their price objective on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Brookline Capital Management lowered shares of Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 21st. Wall Street Zen lowered shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Oppenheimer lowered shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd. Finally, Canaccord Genuity Group restated a “hold” rating and set a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a research report on Wednesday, September 10th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions has a consensus rating of “Hold” and a consensus price target of $4.17.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.